The new cardiovascular disease prevention program is very expensive and does not reduce mortality rates, according to the chairman of the Latvian Association of Doctors and Dentists (LASA), University of Texas professor and endocrinologist Ugis Gruntmanis.
According to him, there is no evidence that preventive measures All, including low-risk patients, reduce mortality, therefore, people with an increased risk of cardiovascular disease should be identified and these patients should be treated. The program is "throwing in the wind," says Laza, chairman.
At the same time, he pointed out that women did not even have to start a screening program from the age of 40, but from the age of 50. This practice is also recommended in the 2016 European Cardiovascular Disease Prevention Guidelines, which contain various recommendations that the Ministry of Health (VM) has not taken into account but has done exactly the opposite.
As indicated in the guidelines, screening for low-risk patients is not effective reduce cardiovascular events. "The cost of such screening interventions is high, although resources can be used better for high-risk patients or patients who already have cardiovascular disease," says the guidelines.
It has already been reported that this year two new national healthcare programs – cardiovascular disease Anda Čakša (ZZS), Minister of Health, said today at a press conference today, at a press conference, for the prevention of chronic care of patients in hospitals – 4.7 million euros. The program foresees two million euros this year, € 2.6 million in 2019, € 3.2 million in 2020.
Chaksa said that the cardiovascular disease prevention program is aimed at increasing the survival rate, and it will manifest itself as a set of healthcare checks at the family doctor, starting at age 40, every five years. The minister added that last year 15,838 people died from cardiovascular disease.